Implantable Cardioverter-Defibrillator Insertion in Congenital Heart Disease Without Transvenous Access to the Heart

被引:7
|
作者
Nery, Pablo B. [1 ]
Green, Martin S. [1 ]
Khairy, Paul [2 ]
Alhebaishi, Yahya [1 ]
Hendry, Paul [1 ]
Birnie, David H. [1 ]
机构
[1] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada
[2] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
关键词
PLACEMENT; LEAD;
D O I
10.1016/j.cjca.2012.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sudden cardiac death is the leading cause of mortality in adults with complex congenital heart disease. Challenges to implanting cardioverter-defibrillators (ICDs) may arise as a result of vascular or intracardiac access issues. For example, conduits may divert systemic venous return to extracardiac structures such as pulmonary arteries or tunnels. Creative approaches to ICD implantation have previously involved subcutaneous arrays, often associated with thoracotomy to implant intrathoracic coils. We describe a patient with complex congenital heart disease and no transvenous access via the superior vena cave in whom ICD implantation involved placement of a coil within the azygos vein.
引用
收藏
页码:254.e1 / 254.e3
页数:3
相关论文
共 50 条
  • [21] IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WHO HAVE GENETIC HEART DISEASE
    McGriff, Deepa
    Protas, Matthew
    Katsiyiannis, William
    Kallinen, Linda
    Hauser, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E360 - E360
  • [22] Current status of implantable cardioverter-defibrillator therapy in heart failure
    Can I.
    Tholakanahalli V.N.
    Current Heart Failure Reports, 2009, 6 (3) : 199 - 209
  • [23] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Al-Majed, Nawaf S.
    Ezekowitz, Justin A.
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 299 - 307
  • [24] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Nawaf S. Al-Majed
    Justin A. Ezekowitz
    Current Cardiology Reports, 2012, 14 : 299 - 307
  • [25] IMPLANTATION OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN THE HEART-TRANSPLANT CANDIDATE
    EMERY, RW
    ALMQUIST, AK
    VONRUEDEN, TJ
    PRITZKER, MR
    AROM, KV
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1993, 12 (06): : 1067 - 1070
  • [26] Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure
    Böcker, D
    Bänsch, D
    Heinecke, A
    Weber, M
    Brunn, J
    Hammel, D
    Borggrefe, M
    Breithardt, G
    Block, P
    CIRCULATION, 1998, 98 (16) : 1636 - 1643
  • [27] Functional Classes of Heart Failure and Indications for Implantable Cardioverter-Defibrillator
    Guglin, Maya
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (01): : 182 - 182
  • [28] Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population
    Ahmadi-Kashani, Mastaneh
    Kessler, David J.
    Day, John
    Bunch, T. Jared
    Stolen, Kira Q.
    Brown, Scott
    Sbaity, Salam
    Olshansky, Brian
    CIRCULATION, 2009, 120 (21) : 2040 - 2045
  • [29] Implantable cardioverter-defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study
    Slater, Thomas A.
    Cupido, Blanche
    Parry, Helen
    Drozd, Michael
    Blackburn, Michael E.
    Hares, Dominic
    Pepper, Christopher B.
    Birkitt, Linda
    Cullington, Damien
    Witte, Klaus K.
    Oliver, James
    English, Kate M.
    Sengupta, Anshuman
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (08) : 2086 - 2092
  • [30] Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping
    Zeb, Mehmood
    Curzen, Nicholas
    Veldtman, Gruschen
    Yue, Arthur
    Roberts, Paul
    Wilson, David
    Morgan, John
    EUROPACE, 2015, 17 (07): : 1059 - 1067